Biochemistry and biomedical chemistry
Gene editing (CRISPR)
CRISPR–Cas systems turn guide-directed nucleic-acid recognition into a programmable genome-targeting tool.
IntuitionIntuition: the central idea
CRISPR–Cas systems turn guide-directed nucleic-acid recognition into a programmable genome-targeting tool.
SchoolSchool level: key concepts and a first application
Definition: Core concept
SpCas9 uses a guide RNA to pair with a target next to a PAM, then creates a double-strand break. NHEJ can introduce indels; HDR can use a donor template.
CRISPR systems inherited from bacterial adaptive immunity pair a guide RNA with a nuclease such as Cas9. The DNA double-strand break is resolved by cell repair: end-joining tends to knock genes out, homology-directed repair can write edits.
| Term | Interpretation |
|---|---|
| Guide RNA | A short RNA that directs Cas proteins to a complementary target. |
| PAM | Short DNA motif next to the target required by many Cas nucleases. |
| HDR | Homology-directed repair using a donor template. |
Example: Apply the idea
Why can the same CRISPR nuclease produce different sequence outcomes in different cells?
Solution
The nuclease creates a lesion, but repair pathway choice, cell cycle, donor availability and local sequence context shape the final allele.
UndergraduateUniversity level: quantitative description
Editing outcome is not only about cutting: guide binding kinetics, PAM availability, chromatin accessibility and repair pathway biases all matter.
AdvancedAdvanced: assumptions and mechanistic detail
Beyond SpCas9, Cas12a, base editors, prime editors and epigenome editors offer different trade-offs: PAM range, nicking, double-strand breaks, precision and delivery constraints differ.
ResearchResearch frontier: open questions and current practice
References
- A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity · Martin Jinek; Krzysztof Chylinski; Ines Fonfara; Michael Hauer; Jennifer A. Doudna; Emmanuelle Charpentier, 2012
- The new frontier of genome engineering with CRISPR-Cas9 · Jennifer A. Doudna; Emmanuelle Charpentier, 2014